Iris Luo

Iris Luo is an experienced professional in licensing and business development, currently serving as AVP of Business Development & Alliance Management at CStone Pharmaceuticals since September 2018. Prior to this role, Iris operated as an Independent Consultant at Bionetwork Consulting, LLC for nearly a decade, advising biotech firms on business strategy, financial valuation, commercial forecasts, and partnership development. Iris has also held significant positions at Cephalon as Associate Director of Licensing and Business Development, where key contributions included leading valuation efforts and contract negotiations for pharmaceutical acquisitions, and at Johnson & Johnson in various senior financial analyst roles, focusing on sales forecasting, financial reporting, and analysis for business development projects. Earlier expertise includes work as a Staff Scientist at DuPont Pharmaceuticals, which involved managing drug discovery projects and contributing to scientific publications. Iris holds an M.S. in Biochemistry from the University of Pennsylvania, a B.S. in Chemistry from Peking University, and an MBA in Finance from Cornell Johnson Graduate School of Management.